LEVOCETIRIZIN TAD 5 mg film-coated tablets, 50 pcs

Instructions for use for LEVOCETIRIZIN TAD 5 mg film-coated tablets, 50 pcs

Information for use with the article Levocetirizine TAD 5 mg Film-coated tablets: - Levocetirizine TAD 5 mg Film-coated tablets contain the active substance levocetirizine dihydrochloride and are used to treat symptoms of allergic rhinitis (including persistent allergic rhinitis) and hives (urticaria). - The recommended dose for adults and children 6 years and older is 1 film-coated tablet daily. - Patients with impaired kidney or liver function should adjust the dose accordingly. - Elderly patients do not require dose adjustment provided their renal function is normal. - Levocetirizine TAD should not be used in children under 6 years of age. - The film-coated tablets should be taken unchewed with water, regardless of meals. - The duration of use depends on the type, duration and course of the symptoms and is determined by the doctor. - Levocetirizine TAD should be protected from children and should not be used after the expiry date. - Possible side effects may include headache, drowsiness, dry mouth, tiredness, fatigue and abdominal pain. - Levocetirizine TAD contains 5 mg levocetirizine dihydrochloride and other ingredients such as lactose. - Before use, possible contraindications should be considered, e.g. hypersensitivity to the ingredients or severe renal impairment. - During pregnancy and lactation, the use should be discussed with a doctor. - No large quantities of the medicinal product should be disposed of in sewage or household waste. - Levocetirizine TAD acts as a second-generation antihistamine and blocks the action of histamine, thereby reducing allergic symptoms. - In case of intolerance to lactose or diabetes, the sugar content should be taken into account. - Interactions with other medicines are possible and should be discussed with a doctor or pharmacist before starting treatment. Source: Package leaflet Levocetirizine TAD, as of 04/2023